Cargando…

APASL consensus statements and recommendation on treatment of hepatitis C

The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Omata, Masao, Kanda, Tatsuo, Wei, Lai, Yu, Ming-Lung, Chuang, Wang-Long, Ibrahim, Alaaeldin, Lesmana, Cosmas Rinaldi Adithya, Sollano, Jose, Kumar, Manoj, Jindal, Ankur, Sharma, Barjesh Chander, Hamid, Saeed S., Dokmeci, A. Kadir, Mamun-Al-Mahtab, McCaughan, Geofferey W., Wasim, Jafri, Crawford, Darrell H. G., Kao, Jia-Horng, Yokosuka, Osamu, Lau, George K. K., Sarin, Shiv Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003907/
https://www.ncbi.nlm.nih.gov/pubmed/27130427
http://dx.doi.org/10.1007/s12072-016-9717-6
_version_ 1782450702545584128
author Omata, Masao
Kanda, Tatsuo
Wei, Lai
Yu, Ming-Lung
Chuang, Wang-Long
Ibrahim, Alaaeldin
Lesmana, Cosmas Rinaldi Adithya
Sollano, Jose
Kumar, Manoj
Jindal, Ankur
Sharma, Barjesh Chander
Hamid, Saeed S.
Dokmeci, A. Kadir
Mamun-Al-Mahtab
McCaughan, Geofferey W.
Wasim, Jafri
Crawford, Darrell H. G.
Kao, Jia-Horng
Yokosuka, Osamu
Lau, George K. K.
Sarin, Shiv Kumar
author_facet Omata, Masao
Kanda, Tatsuo
Wei, Lai
Yu, Ming-Lung
Chuang, Wang-Long
Ibrahim, Alaaeldin
Lesmana, Cosmas Rinaldi Adithya
Sollano, Jose
Kumar, Manoj
Jindal, Ankur
Sharma, Barjesh Chander
Hamid, Saeed S.
Dokmeci, A. Kadir
Mamun-Al-Mahtab
McCaughan, Geofferey W.
Wasim, Jafri
Crawford, Darrell H. G.
Kao, Jia-Horng
Yokosuka, Osamu
Lau, George K. K.
Sarin, Shiv Kumar
author_sort Omata, Masao
collection PubMed
description The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12072-016-9717-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5003907
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-50039072016-09-15 APASL consensus statements and recommendation on treatment of hepatitis C Omata, Masao Kanda, Tatsuo Wei, Lai Yu, Ming-Lung Chuang, Wang-Long Ibrahim, Alaaeldin Lesmana, Cosmas Rinaldi Adithya Sollano, Jose Kumar, Manoj Jindal, Ankur Sharma, Barjesh Chander Hamid, Saeed S. Dokmeci, A. Kadir Mamun-Al-Mahtab McCaughan, Geofferey W. Wasim, Jafri Crawford, Darrell H. G. Kao, Jia-Horng Yokosuka, Osamu Lau, George K. K. Sarin, Shiv Kumar Hepatol Int Guidelines The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12072-016-9717-6) contains supplementary material, which is available to authorized users. Springer India 2016-04-29 /pmc/articles/PMC5003907/ /pubmed/27130427 http://dx.doi.org/10.1007/s12072-016-9717-6 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Guidelines
Omata, Masao
Kanda, Tatsuo
Wei, Lai
Yu, Ming-Lung
Chuang, Wang-Long
Ibrahim, Alaaeldin
Lesmana, Cosmas Rinaldi Adithya
Sollano, Jose
Kumar, Manoj
Jindal, Ankur
Sharma, Barjesh Chander
Hamid, Saeed S.
Dokmeci, A. Kadir
Mamun-Al-Mahtab
McCaughan, Geofferey W.
Wasim, Jafri
Crawford, Darrell H. G.
Kao, Jia-Horng
Yokosuka, Osamu
Lau, George K. K.
Sarin, Shiv Kumar
APASL consensus statements and recommendation on treatment of hepatitis C
title APASL consensus statements and recommendation on treatment of hepatitis C
title_full APASL consensus statements and recommendation on treatment of hepatitis C
title_fullStr APASL consensus statements and recommendation on treatment of hepatitis C
title_full_unstemmed APASL consensus statements and recommendation on treatment of hepatitis C
title_short APASL consensus statements and recommendation on treatment of hepatitis C
title_sort apasl consensus statements and recommendation on treatment of hepatitis c
topic Guidelines
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003907/
https://www.ncbi.nlm.nih.gov/pubmed/27130427
http://dx.doi.org/10.1007/s12072-016-9717-6
work_keys_str_mv AT omatamasao apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT kandatatsuo apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT weilai apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT yuminglung apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT chuangwanglong apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT ibrahimalaaeldin apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT lesmanacosmasrinaldiadithya apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT sollanojose apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT kumarmanoj apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT jindalankur apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT sharmabarjeshchander apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT hamidsaeeds apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT dokmeciakadir apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT mamunalmahtab apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT mccaughangeoffereyw apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT wasimjafri apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT crawforddarrellhg apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT kaojiahorng apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT yokosukaosamu apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT laugeorgekk apaslconsensusstatementsandrecommendationontreatmentofhepatitisc
AT sarinshivkumar apaslconsensusstatementsandrecommendationontreatmentofhepatitisc